Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07533643Completed
Randomised, double-blind trial of lidocaine 10% oropharyngeal spray (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Maximum change in systolic blood pressure. Started Aug 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07533643.